immunotherapy tagged posts

This experimental “super vaccine” stopped cancer cold in the lab

“Super Vaccine” Stopped Cancer Cold in the Lab
UMass Amherst scientists created a nanoparticle “super adjuvant” vaccine that prevented melanoma, pancreatic, and breast cancers in mice. The innovation primes the immune system for lasting, body-wide protection against cancer spread. Credit: Shutterstock

Researchers at the University of Massachusetts Amherst have shown that their nanoparticle-based vaccine can successfully prevent several aggressive cancers in mice, including melanoma, pancreatic cancer, and triple-negative breast cancer. Depending on the cancer type, up to 88% of vaccinated mice stayed tumor-free (depending on the cancer), and the vaccine also reduced — and in some cases completely prevented — the spread of cancer throughout the body.

“By engineering these nanoparticles to activate the immune system via multi-...

Read More

Surprising finding could pave way for universal cancer vaccine

An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to “wake up” the immune system against cancer.

Published in Nature Biomedical Engineering, the University of Florida study showed that like a one-two punch, pairing the test vaccine with common anticancer drugs called immune checkpoint inhibitors triggered a strong antitumor response.

A surprising element, researchers said, was that they achieved the promising results not by attacking a specific target protein expressed in the tumor, but by simply revving up the immune system—spurring it to respond as if fighting a virus...

Read More

Immunotherapy Significantly Increases the Number of Patients Free from Bowel Cancer: Clinical trial

chemotherapy
Credit: Unsplash/CC0 Public Domain

An immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more patients with a certain genetic profile were cancer-free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.

The findings, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024, are interim results from the NEOPRISM-CRC phase II clinical trial assessing whether the immunotherapy drug pembrolizumab can improve outcomes for patients with stage two or stage three MMR deficient/MSI-High bowel cancer. The trial was a collaboration among UCL, UCLH, the Christie NHS Foundation Trust in Manchester, St...

Read More

Researchers Develop a New Way to Safely Boost Immune Cells to Fight Cancer

Researchers develop a new way to safely boost immune cells to fight cancer
(Standing, from left) Rong Tong, associate professor in chemical engineering; Wenjun “Rebecca” Cai, associate professor in materials science and engineering; Eungyo Jang; and Ziyu Huo gather around Liqian Niu (seated), who is working with a Luminex 200 machine used to analyze tumor cytokine levels. Credit: Hailey Wade for Virginia Tech.

Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped medical progress in developing treatment procedures that are less invasive while still highly effective.

Immunotherapy is on the rise as a possible solution...

Read More